234 related articles for article (PubMed ID: 23991149)
41. Cap-binding protein 1-mediated and eukaryotic translation initiation factor 4E-mediated pioneer rounds of translation in yeast.
Gao Q; Das B; Sherman F; Maquat LE
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4258-63. PubMed ID: 15753296
[TBL] [Abstract][Full Text] [Related]
42. Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs.
Rong L; Livingstone M; Sukarieh R; Petroulakis E; Gingras AC; Crosby K; Smith B; Polakiewicz RD; Pelletier J; Ferraiuolo MA; Sonenberg N
RNA; 2008 Jul; 14(7):1318-27. PubMed ID: 18515545
[TBL] [Abstract][Full Text] [Related]
43. Structural changes of eIF4E upon binding to the mRNA 5' monomethylguanosine and trimethylguanosine Cap.
Rutkowska-Wlodarczyk I; Stepinski J; Dadlez M; Darzynkiewicz E; Stolarski R; Niedzwiecka A
Biochemistry; 2008 Mar; 47(9):2710-20. PubMed ID: 18220364
[TBL] [Abstract][Full Text] [Related]
44. capCLIP: a new tool to probe translational control in human cells through capture and identification of the eIF4E-mRNA interactome.
Jensen KB; Dredge BK; Toubia J; Jin X; Iadevaia V; Goodall GJ; Proud CG
Nucleic Acids Res; 2021 Oct; 49(18):e105. PubMed ID: 34255842
[TBL] [Abstract][Full Text] [Related]
45. Ectopic expression of eIF4E-transporter triggers the movement of eIF4E into P-bodies, inhibiting steady-state translation but not the pioneer round of translation.
Lee HC; Cho H; Kim YK
Biochem Biophys Res Commun; 2008 May; 369(4):1160-5. PubMed ID: 18343217
[TBL] [Abstract][Full Text] [Related]
46. Cap-binding activity of an eIF4E homolog from Leishmania.
Yoffe Y; Zuberek J; Lewdorowicz M; Zeira Z; Keasar C; Orr-Dahan I; Jankowska-Anyszka M; Stepinski J; Darzynkiewicz E; Shapira M
RNA; 2004 Nov; 10(11):1764-75. PubMed ID: 15388875
[TBL] [Abstract][Full Text] [Related]
47. Localisation and regulation of the eIF4E-binding protein 4E-BP3.
Kleijn M; Scheper GC; Wilson ML; Tee AR; Proud CG
FEBS Lett; 2002 Dec; 532(3):319-23. PubMed ID: 12482586
[TBL] [Abstract][Full Text] [Related]
48. Diverse cap-binding properties of Drosophila eIF4E isoforms.
Zuberek J; Kuchta K; Hernández G; Sonenberg N; Ginalski K
Biochim Biophys Acta; 2016 Oct; 1864(10):1292-303. PubMed ID: 27374989
[TBL] [Abstract][Full Text] [Related]
49. GIGYF1/2 proteins use auxiliary sequences to selectively bind to 4EHP and repress target mRNA expression.
Peter D; Weber R; Sandmeir F; Wohlbold L; Helms S; Bawankar P; Valkov E; Igreja C; Izaurralde E
Genes Dev; 2017 Jun; 31(11):1147-1161. PubMed ID: 28698298
[TBL] [Abstract][Full Text] [Related]
50. Discovery and characterization of conserved binding of eIF4E 1 (CBE1), a eukaryotic translation initiation factor 4E-binding plant protein.
Patrick RM; Lee JCH; Teetsel JRJ; Yang SH; Choy GS; Browning KS
J Biol Chem; 2018 Nov; 293(44):17240-17247. PubMed ID: 30213859
[TBL] [Abstract][Full Text] [Related]
51. Translational repression by human 4E-BP1 in yeast specifically requires human eIF4E as target.
Hughes JM; Ptushkina M; Karim MM; Koloteva N; von der Haar T; McCarthy JE
J Biol Chem; 1999 Feb; 274(6):3261-4. PubMed ID: 9920863
[TBL] [Abstract][Full Text] [Related]
52. Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein.
Shih JW; Tsai TY; Chao CH; Wu Lee YH
Oncogene; 2008 Jan; 27(5):700-14. PubMed ID: 17667941
[TBL] [Abstract][Full Text] [Related]
53. Xenopus CAF1 requires NOT1-mediated interaction with 4E-T to repress translation in vivo.
Waghray S; Williams C; Coon JJ; Wickens M
RNA; 2015 Jul; 21(7):1335-45. PubMed ID: 26015597
[TBL] [Abstract][Full Text] [Related]
54. Control of the eIF4E activity: structural insights and pharmacological implications.
Romagnoli A; D'Agostino M; Ardiccioni C; Maracci C; Motta S; La Teana A; Di Marino D
Cell Mol Life Sci; 2021 Nov; 78(21-22):6869-6885. PubMed ID: 34541613
[TBL] [Abstract][Full Text] [Related]
55. The 4E-BP Caf20p Mediates Both eIF4E-Dependent and Independent Repression of Translation.
Castelli LM; Talavera D; Kershaw CJ; Mohammad-Qureshi SS; Costello JL; Rowe W; Sims PF; Grant CM; Hubbard SJ; Ashe MP; Pavitt GD
PLoS Genet; 2015 May; 11(5):e1005233. PubMed ID: 25973932
[TBL] [Abstract][Full Text] [Related]
56. The eIF4E2-Directed Hypoxic Cap-Dependent Translation Machinery Reveals Novel Therapeutic Potential for Cancer Treatment.
Melanson G; Timpano S; Uniacke J
Oxid Med Cell Longev; 2017; 2017():6098107. PubMed ID: 29317983
[TBL] [Abstract][Full Text] [Related]
57. Roles and interactions of the specialized initiation factors EIF4E2, EIF4E5, and EIF4E6 in Trypanosoma brucei: EIF4E2 maintains the abundances of S-phase mRNAs.
Falk F; Melo Palhares R; Waithaka A; Clayton C
Mol Microbiol; 2022 Oct; 118(4):457-476. PubMed ID: 36056730
[TBL] [Abstract][Full Text] [Related]
58. Binding of eukaryotic translation initiation factor 4E (eIF4E) to eIF4G represses translation of uncapped mRNA.
Tarun SZ; Sachs AB
Mol Cell Biol; 1997 Dec; 17(12):6876-86. PubMed ID: 9372919
[TBL] [Abstract][Full Text] [Related]
59. A Novel Interaction Network Used by Potyviruses in Virus-Host Interactions at the Protein Level.
Ala-Poikela M; Rajamäki ML; Valkonen JPT
Viruses; 2019 Dec; 11(12):. PubMed ID: 31847316
[TBL] [Abstract][Full Text] [Related]
60. Nutritional stress affects an atypical cap-binding protein in Leishmania.
Zinoviev A; Manor S; Shapira M
RNA Biol; 2012 Dec; 9(12):1450-60. PubMed ID: 23135001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
